These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
967 related items for PubMed ID: 16123145
1. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M. Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145 [Abstract] [Full Text] [Related]
2. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H. J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415 [Abstract] [Full Text] [Related]
3. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H. Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413 [Abstract] [Full Text] [Related]
4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H. J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209 [Abstract] [Full Text] [Related]
5. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Beschorner R, Nguyen TD, Gözalan F, Pedal I, Mattern R, Schluesener HJ, Meyermann R, Schwab JM. Acta Neuropathol; 2002 Jun; 103(6):541-9. PubMed ID: 12012085 [Abstract] [Full Text] [Related]
6. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P. J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488 [Abstract] [Full Text] [Related]
7. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. Airas L, Nikula T, Huang YH, Lahesmaa R, Wiendl H. J Neuroimmunol; 2007 Jul; 187(1-2):205-11. PubMed ID: 17561269 [Abstract] [Full Text] [Related]
8. HLA Class I protein expression in the human placenta. Blaschitz A, Hutter H, Dohr G. Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519 [Abstract] [Full Text] [Related]
9. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. Koning N, Swaab DF, Hoek RM, Huitinga I. J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626 [Abstract] [Full Text] [Related]
10. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Ulvestad E, Williams K, Bø L, Trapp B, Antel J, Mørk S. Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916 [Abstract] [Full Text] [Related]
11. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis. Fainardi E, Rizzo R, Castellazzi M, Stignani M, Granieri E, Baricordi OR. Hum Immunol; 2009 Dec; 70(12):981-7. PubMed ID: 19651179 [Abstract] [Full Text] [Related]
12. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E. Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350 [Abstract] [Full Text] [Related]
13. HLA-G expression in human embryonic stem cells and preimplantation embryos. Verloes A, Van de Velde H, LeMaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M. J Immunol; 2011 Feb 15; 186(4):2663-71. PubMed ID: 21248264 [Abstract] [Full Text] [Related]
14. CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. Fainardi E, Rizzo R, Melchiorri L, Stignani M, Castellazzi M, Tamborino C, Paolino E, Tola MR, Granieri E, Baricordi OR. Mult Scler; 2008 May 15; 14(4):446-54. PubMed ID: 18208868 [Abstract] [Full Text] [Related]
15. Expression and regulation of non-classical HLA-G in renal cell carcinoma. Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B. Tissue Antigens; 2008 Aug 15; 72(2):137-48. PubMed ID: 18721274 [Abstract] [Full Text] [Related]
16. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A, Paul P. Cancer Res; 2001 Sep 15; 61(18):6838-45. PubMed ID: 11559559 [Abstract] [Full Text] [Related]
17. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Bukur J, Rebmann V, Grosse-Wilde H, Luboldt H, Ruebben H, Drexler I, Sutter G, Huber C, Seliger B. Cancer Res; 2003 Jul 15; 63(14):4107-11. PubMed ID: 12874014 [Abstract] [Full Text] [Related]
18. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E? Wischhusen J, Waschbisch A, Wiendl H. Semin Cancer Biol; 2007 Dec 15; 17(6):459-68. PubMed ID: 17768067 [Abstract] [Full Text] [Related]
19. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Paul P, Cabestré FA, Le Gal FA, Khalil-Daher I, Le Danff C, Schmid M, Mercier S, Avril MF, Dausset J, Guillet JG, Carosella ED. Cancer Res; 1999 Apr 15; 59(8):1954-60. PubMed ID: 10213506 [Abstract] [Full Text] [Related]
20. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. Le Friec G, Gros F, Sebti Y, Guilloux V, Pangault C, Fauchet R, Amiot L. J Leukoc Biol; 2004 Dec 15; 76(6):1125-33. PubMed ID: 15331623 [Abstract] [Full Text] [Related] Page: [Next] [New Search]